Drug
ALV003
ALV003 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
3
75%
Ph phase_1
1
25%
Phase Distribution
1
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (25.0%)
Phase 23 (75.0%)
Trials by Status
completed375%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
unknownphase_2
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
NCT01917630
completedphase_2
Safety and Efficacy of ALV003 for the Treatment of Celiac Disease
NCT00959114
completedphase_2
Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease
NCT01255696
completedphase_1
Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal
NCT00669825
Clinical Trials (4)
Showing 4 of 4 trials
NCT01917630Phase 2
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
NCT00959114Phase 2
Safety and Efficacy of ALV003 for the Treatment of Celiac Disease
NCT01255696Phase 2
Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease
NCT00669825Phase 1
Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4